CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to BIIB

Felzartamab

Phase 3
Biogen Inc. (BIIB)

Phase 3

Development Phase

2

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q2 '27
BIIBPhase 3

Felzartamab Phase 3 Est. Readout (PREVAIL)

Felzartamab
Q2 2027~Q
CT.gov
00%
Dec '26
BIIBPhase 3

Felzartamab Phase 3 Est. Readout (TRANSCEND)

Felzartamab
Dec 2026~
CT.gov
00%
Competitive Landscape

1 competitor in Primary Membranous Nephropathy

View Full Landscape
Drug Information

Target Indication

Primary Membranous Nephropathy

Clinical Trial

NCT06962800

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.